1. Home
  2. TSHA vs CCSI Comparison

TSHA vs CCSI Comparison

Compare TSHA & CCSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSHA
  • CCSI
  • Stock Information
  • Founded
  • TSHA 2019
  • CCSI 2021
  • Country
  • TSHA United States
  • CCSI United States
  • Employees
  • TSHA N/A
  • CCSI N/A
  • Industry
  • TSHA Biotechnology: Pharmaceutical Preparations
  • CCSI Retail: Computer Software & Peripheral Equipment
  • Sector
  • TSHA Health Care
  • CCSI Technology
  • Exchange
  • TSHA Nasdaq
  • CCSI Nasdaq
  • Market Cap
  • TSHA 403.7M
  • CCSI 476.8M
  • IPO Year
  • TSHA 2020
  • CCSI N/A
  • Fundamental
  • Price
  • TSHA $2.04
  • CCSI $24.33
  • Analyst Decision
  • TSHA Strong Buy
  • CCSI Hold
  • Analyst Count
  • TSHA 8
  • CCSI 5
  • Target Price
  • TSHA $6.63
  • CCSI $26.00
  • AVG Volume (30 Days)
  • TSHA 5.4M
  • CCSI 95.2K
  • Earning Date
  • TSHA 11-13-2024
  • CCSI 11-07-2024
  • Dividend Yield
  • TSHA N/A
  • CCSI N/A
  • EPS Growth
  • TSHA N/A
  • CCSI 16.33
  • EPS
  • TSHA N/A
  • CCSI 4.56
  • Revenue
  • TSHA $9,915,000.00
  • CCSI $351,153,000.00
  • Revenue This Year
  • TSHA N/A
  • CCSI N/A
  • Revenue Next Year
  • TSHA N/A
  • CCSI N/A
  • P/E Ratio
  • TSHA N/A
  • CCSI $5.31
  • Revenue Growth
  • TSHA N/A
  • CCSI N/A
  • 52 Week Low
  • TSHA $1.19
  • CCSI $11.62
  • 52 Week High
  • TSHA $4.32
  • CCSI $27.90
  • Technical
  • Relative Strength Index (RSI)
  • TSHA 42.15
  • CCSI 48.35
  • Support Level
  • TSHA $1.97
  • CCSI $24.36
  • Resistance Level
  • TSHA $2.72
  • CCSI $25.50
  • Average True Range (ATR)
  • TSHA 0.24
  • CCSI 1.00
  • MACD
  • TSHA -0.10
  • CCSI -0.18
  • Stochastic Oscillator
  • TSHA 4.48
  • CCSI 19.01

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

About CCSI Consensus Cloud Solutions Inc.

Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.

Share on Social Networks: